Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 1;31(6):641-853.
doi: 10.5551/jat.GL2022. Epub 2023 Dec 19.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Tomonori Okamura  1 , Kazuhisa Tsukamoto  2 , Hidenori Arai  3 , Yoshio Fujioka  4 , Yasushi Ishigaki  5 , Shinji Koba  6 , Hirotoshi Ohmura  7 , Tetsuo Shoji  8 , Koutaro Yokote  9 , Hiroshi Yoshida  10 , Masayuki Yoshida  11 , Juno Deguchi  12 , Kazushige Dobashi  13 , Akira Fujiyoshi  14 , Hirotoshi Hamaguchi  15 , Masumi Hara  16 , Mariko Harada-Shiba  17   18 , Takumi Hirata  19 , Mami Iida  20 , Yoshiyuki Ikeda  21 , Shun Ishibashi  22   23 , Hideyuki Kanda  24 , Shinji Kihara  25 , Kazuo Kitagawa  26 , Satoru Kodama  27 , Masahiro Koseki  28 , Yoshiro Maezawa  9 , Daisaku Masuda  29 , Takashi Miida  30 , Yoshihiro Miyamoto  31 , Rimei Nishimura  32 , Koichi Node  33 , Midori Noguchi  34 , Mitsuru Ohishi  21 , Isao Saito  35 , Shojiro Sawada  36 , Hirohito Sone  37 , Minoru Takemoto  38 , Akihiko Wakatsuki  39 , Hidekatsu Yanai  40
Affiliations

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Tomonori Okamura et al. J Atheroscler Thromb. .
No abstract available

PubMed Disclaimer

Figures

Fig.1. Excess relative risk when set at 0% for nonsmoking and 100% for 20 cigarettes/day
Fig.1. Excess relative risk when set at 0% for nonsmoking and 100% for 20 cigarettes/day
Adapted from Hackshaw A. et al. BMJ, 2018; 360: j5855.
Fig.2.Relationship between the number of concurrent risk factors and death due to CAD and stroke
Fig.2.Relationship between the number of concurrent risk factors and death due to CAD and stroke
(NIPPON DATA80: 1980-1994) (Nakamura Y et al : Circ J 70: 960-964, 2006)
Fig.3.
Fig.3.
Flowchart for setting lipid management _targets from the viewpoint of ASCVD prevention
Fig.4.
Fig.4.
Prediction model for the onset of ASCVD using the Hisayama score
Table 5.
Table 5.
_target values for lipid management by risk category
Fig.5.
Fig.5.
The Alcohol Use Disorders Identification Test (AUDIT)
Fig.6. Exercise Guidelines for Health Promotion 2006
Fig.6. Exercise Guidelines for Health Promotion 2006
Translated and reprinted from Health Promotion Exercise Guidelines 2003, Ministry of Health, Labour and Welfare, Japan
Fig. 7. Physical Activity Guidelines for Health Promotion 2013
Fig. 7. Physical Activity Guidelines for Health Promotion 2013
Fig.8.
Fig.8.
Comprehensive risk management chart for cerebral and cardiovascular disease prevention
Fig. 11.
Fig. 11.
Flowchart of treatment for pediatric FH heterozygotes (under the age of 15)
Fig. 9.
Fig. 9.
Flowchart of HeFH treatment in adults (15 years and older)
Fig.10.
Fig.10.
Flowchart of HoFH treatment in adults (15 years and older)
Fig.12.
Fig.12.
Flowchart for Diagnosis of Primary Hypo‐HDL cholesterolemia
Supplemental Fig.1.
Supplemental Fig.1.
10‐year risk of incidence of atherosclerotic cardiovascular disease; age scored version
Supplemental Fig.2. Flowchart for cardiovascular event screening in NAFLD<sup>*</sup> patients
Supplemental Fig.2. Flowchart for cardiovascular event screening in NAFLD* patients
We have to check for cardiovascular disease (CVD) complications and/or a past history of CVD, and perform an electrocardiogram (ECG). If any abnormality is found, we consult a specialist in cardiology or neurology. In NAFLD with a reduced platelet count or increased FIB-4 index, we should evaluate risk based on cardiovascular examination, such as loaded ECG and/or US of the carotid artery. FIB-4 index Fibrosis-4 index; PLT platelet, DM diabetes mellitus; HT hypertension, DL dyslipidemia; US ultrasonography; ECG electrocardiogram *NAFLD: Currently MASLD Tokushige K, et al.: Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J Gastroenterol, 2021; 56: 951‐963
Supplemental Fig.3.
Supplemental Fig.3.
‘Where am I?’ chart
Supplementary Fig.4.
Supplementary Fig.4.
Positions and probes
Supplementary Fig.5. Short-axis cross-sectional image
Supplementary Fig.5. Short-axis cross-sectional image
Measure the thickness of the tendon in the direction of maximum thickness with the direction of torsion (white arrow) in mind.
Supplementary Fig.6. Long-axis cross-sectional image
Supplementary Fig.6. Long-axis cross-sectional image
Long‐axis cross‐sectional image in the torsion direction from the white arrow site of the short‐axis image
Supplementary Fig.7
Supplementary Fig.7
Supplementary Fig.8
Supplementary Fig.8
Supplementary Fig.9
Supplementary Fig.9
Supplementary Fig.10
Supplementary Fig.10
There are roughly three types of Achilles tendon images. The rightmost image shows the difference between fat and Achilles tendon and Achilles tendon and skin, both of which are suitable for measuring thickening. The numerical difference between each image is large, which makes the image suitable for measuring the Achilles tendon.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Subcommittee for preparing guidelines for ultrasound diagnosis of carotid artery: Standard method for ultrasound evaluation of carotid artery lesions 2017. Jpn J Med Ultrasonics, 2018. https://www.jsum.or.jp/committee/diagnostic/pdf/jsum0515_guideline.pdf; 2018 (in Japanese)
    1. Homma S, Hirose N, Ishida H, Ishii T, Araki G: Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke, 2001; 32: 830-835 - PubMed
    1. Nezu T, Hosomi N, Aoki S, Matsumoto M: Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb, 2016; 23: 18-31 - PubMed
    1. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr.: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 1999; 340: 14-22 - PubMed
    1. del Sol AI, Moons KG, Hollander M, Hofman A, Koudstaal PJ, Grobbee DE, Breteler MM, Witteman JC, Bots ML: Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke, 2001; 32: 1532-1538 - PubMed

MeSH terms

  NODES
Association 1
innovation 2
INTERN 12
twitter 2